Julia Leemput

Dr. Julia Leemput

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2009 in Journal of Experimental Medicine
Verified
Journal Article
Open access
CACedric Auffray
Cedric Auffray
DFDarin K. Fogg
Darin K. Fogg
ENEmilie Narni-Mancinelli
Emilie Narni-Mancinelli
BSBrigitte Senechal
Brigitte Senechal
CTCeline Trouillet
Celine Trouillet
FGFrederic Geissmann
Frederic Geissmann
CX3CR1 expression is associated with the commitment of CSF-1R+ myeloid precursors to the macrophage/dendritic cell (DC) lineage. However, the relationship of the CSF-1R+ CX3CR1+ macrophage/DC precursor (MDP) with other DC precursors and the role of CX3CR1 in macrophage and DC development remain unclear. We show that MDPs give rise to conventional DCs (cDCs), plasmacytoid DCs (PDCs), and monocytes, including Gr1+ inflammatory monocytes that differentiate into TipDCs during infection. CX3CR1 deficiency selectively impairs the recruitment of blood Gr1+ monocytes in the spleen after transfer and during acute Listeria monocytogenes infection but does not affect the development of monocytes, cDCs, and PDCs.

1 August 2009 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
CJCarolina Ofir Jaliffa
Carolina Ofir Jaliffa
IAIlhame Ameqrane
Ilhame Ameqrane
ADAnouk Dansault
Anouk Dansault
JLJulia Leemput
Julia Leemput
VVVe´rOnique Vieira
Ve´rOnique Vieira
MAMarc Abitbol
Marc Abitbol
Purpose. Sirtuin1 (Sirt1) is an NAD+-dependent deacetylase involved in development, cell survival, stress resistance, energy metabolism, and aging. It is expressed in the mammalian central nervous system (CNS) and is activated during processes associated with neuroprotection. The retinal degeneration 10 (rd10) mouse model of retinitis pigmentosa (RP) was used to investigate the possible role of Sirt1 in this type of retinal degeneration.

4 August 2014 in Oncogene
Verified
Journal Article
Closed access
BBB Bardot
B Bardot
RBR Bouarich-Bourimi
R Bouarich-Bourimi
JLJulia Leemput
Julia Leemput
VLV Lejour
V Lejour
AHA Hamon
A Hamon
FTFranck Toledo
Franck Toledo

21 September 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
LBLea Brissard
Lea Brissard
JLJulia Leemput
Julia Leemput
AHAziz Hichami
Aziz Hichami
PPPatricia Passilly-Degrace
Patricia Passilly-Degrace
GMGuillaume Maquart
Guillaume Maquart
Naim KhanNaim Khan
Naim Khan
Obesity is one of the major public health issues, and its prevalence is steadily increasing all the world over. The endocannabinoid system (ECS) has been shown to be involved in the intake of palatable food via activation of cannabinoid 1 receptor (CB1R). However, the involvement of lingual CB1R in the orosensory perception of dietary fatty acids has never been investigated. In the present study, behavioral tests on CB1R−/− and wild type (WT) mice showed that the invalidation of Cb1r gene was associated with low preference for solutions containing rapeseed oil or a long-chain fatty acid (LCFA), such as linoleic acid (LA). Administration of rimonabant, a CB1R inverse agonist, in mice also brought about a low preference for dietary fat. No difference in CD36 and GPR120 protein expressions were observed in taste bud cells (TBC) from WT and CB1R−/− mice. However, LCFA induced a higher increase in [Ca2+]i in TBC from WT mice than that in TBC from CB1R−/− mice. TBC from CB1R−/− mice also exhibited decreased Proglucagon and Glp-1r mRNA and a low GLP-1 basal level. We report that CB1R is involved in fat taste perception via calcium signaling and GLP-1 secretion.

1 December 2007 in Stroke
Verified
Journal Article
Closed access
PDF file
DLDominique Claude Lelong
Dominique Claude Lelong
IBIvan Bieche
Ivan Bieche
EPElodie Perez
Elodie Perez
KBKarine Bigot
Karine Bigot
JLJulia Leemput
Julia Leemput
MAMarc Abitbol
Marc Abitbol
Background and Purpose— Retinal ischemia is a major cause of visual impairment and is associated with a high risk of subsequent ischemic stroke. The retina and its projections are easily accessible for experimental procedures and functional evaluation. We created and characterized a mouse model of global and transient retinal ischemia and provide a comprehensive chronologic profile of some genes that display altered expression during ischemia. Methods— Ischemia and reperfusion were assessed by observing flat-mounted retinas after systemic fluorescein injection. The temporal pattern of gene expression modulation was evaluated by quantitative reverse transcription–polymerase chain reaction from the occurrence of unilateral 30-minute pterygopalatine artery occlusion until 4 weeks after reperfusion. Electroretinograms evaluated functional sequelae 4 weeks after the ischemic episode and were correlated with histologic lesions. Results— This model is the first to reproduce the features of transient monocular amaurosis fugax resulting from ophthalmic artery occlusion. The histologic structure was roughly conserved, but functional lesions affected ganglion cells, inner nuclear layer cells, and photoreceptor cells. We observed an early and strong upregulation of c -fos , c -jun, Cox-2, Hsp70 , and Gadd34 gene expression and a late decrease in Hsp70 transcript levels. Conclusions— A murine model of transient retinal ischemia was successfully developed that exhibited the characteristic upregulation of immediate-early genes and persistent functional deficits. The model should prove useful for investigating mechanisms of injury in genetically altered mice and for testing novel neuroprotective drugs.

Verified
Journal Article
Open access
PDF file
TMTania MULLER
Tania MULLER
LDLaurent Demizieux
Laurent Demizieux
STStéphanie Troy-Fioramonti
Stéphanie Troy-Fioramonti
CBChloé Buch
Chloé Buch
JLJulia Leemput
Julia Leemput
PDPascal Degrace
Pascal Degrace
Targeting cannabinoid 1 receptors (CB1R) with peripherally restricted antagonists (or inverse agonists) shows promise to improve metabolic disorders associated with obesity. In this context, we designed and synthetized JM-00266, a new CB1R blocker with limited blood–brain barrier (BBB) permeability. Pharmacokinetics were tested with SwissADME and in vivo in rodents after oral and intraperitoneal administration of JM-00266 in comparison with Rimonabant. In silico predictions indicated JM-00266 is a non-brain penetrant compound and this was confirmed by brain/plasma ratios and brain uptake index values. JM-00266 had no impact on food intake, anxiety-related behavior and body temperature suggesting an absence of central activity. cAMP assays performed in CB1R-transfected HEK293T/17 cells showed that the drug exhibited inverse agonist activity on CB1R. In addition, JM-00266 counteracted anandamide-induced gastroparesis indicating substantial peripheral activity. Acute administration of JM-00266 also improved glucose tolerance and insulin sensitivity in wild-type mice, but not in CB1R−/− mice. Furthermore, the accumulation of JM-00266 in adipose tissue was associated with an increase in lipolysis. In conclusion, JM-00266 or derivatives can be predicted as a new candidate for modulating peripheral endocannabinoid activity and improving obesity-related metabolic disorders.